RESTORE-3 study demonstrates a 60.4% proptosis response rate versus 23.5% with placebo at Week 24, highlighting the potential ...
Helfie AI ("Helfie"), an AI-powered preventive network transforming global healthcare, announced it has signed a Memorandum ...
Clearance strengthens RingConn’s position in the US wearable health technology market, supporting its expansion in SpO2 ...
(9926.HK) ("Akeso" or the "Company") announced that the first patient has been dosed in a Phase III clinical study ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results